Hobart Private Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Buy |
+1,079
| New | +$200K | 0.05% | 112 |
|
|
2021
Q4 | – | Sell |
-6,653
| Closed | -$718K | – | 42 |
|
|
2021
Q3 | $718K | Sell |
6,653
-2,913
| -30% | -$314K | 0.28% | 46 |
|
|
2021
Q2 | $1.08M | Sell |
9,566
-315
| -3% | -$35.5K | 0.44% | 26 |
|
|
2021
Q1 | $1.07M | Sell |
9,881
-679
| -6% | -$73.5K | 0.44% | 28 |
|
|
2020
Q4 | $1.13M | Sell |
10,560
-835
| -7% | -$89.5K | 0.5% | 26 |
|
|
2020
Q3 | $998K | Sell |
11,395
-6,288
| -36% | -$551K | 0.51% | 29 |
|
|
2020
Q2 | $1.74M | Sell |
17,683
-6,303
| -26% | -$619K | 0.98% | 20 |
|
|
2020
Q1 | $1.83M | Sell |
23,986
-602
| -2% | -$45.9K | 1.25% | 17 |
|
|
2019
Q4 | $2.18M | Buy |
24,588
+1,083
| +5% | +$95.9K | 1.33% | 15 |
|
|
2019
Q3 | $1.78M | Buy |
23,505
+3,282
| +16% | +$249K | 1.21% | 17 |
|
|
2019
Q2 | $1.47M | Buy |
20,223
+1,236
| +7% | +$89.9K | 1.02% | 25 |
|
|
2019
Q1 | $1.53M | Sell |
18,987
-1,171
| -6% | -$94.4K | 1.16% | 24 |
|
|
2018
Q4 | $1.86M | Buy |
20,158
+12,771
| +173% | +$1.18M | 1.59% | 15 |
|
|
2018
Q3 | $699K | Sell |
7,387
-15
| -0.2% | -$1.42K | 0.54% | 53 |
|
|
2018
Q2 | $686K | Sell |
7,402
-3,629
| -33% | -$336K | 0.56% | 57 |
|
|
2018
Q1 | $1.04M | Sell |
11,031
-6,805
| -38% | -$644K | 0.92% | 40 |
|
|
2017
Q4 | $1.72M | Buy |
+17,836
| New | +$1.72M | 1.54% | 21 |
|